FDA Puts Warning of Doubled Risk of Amputation on Invokana Label

Page changed:  SGLT2 Inhibitors, Farxiga, Invokana, Jardiance.Dangerous New Drugs
Note: "Questionable" has been changed to "Dangerous in this page title.

Text Added:

Doubled Risk of Lower Limb Amputations

On May 16, 2017 the FDA ordered that a black box warning be added to the prescribing information for Invokana saying that it doubled the risk of experiencing an amputation. You can read the report about this very important warning in this Medscape news bulletin.